Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion type Assertion NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_head.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion description "[In the FTC-133 cell line, geldanamycin treatment decreased clonogenicity by 21% at a concentration of 50 nM; geldanamycin induced apoptosis and down-regulated c-Raf-1, mutant p53, and epidermal growth factor (EGF) receptor expression; geldanamycin inhibited EGF-stimulated invasion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_provenance.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion evidence source_evidence_literature NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_provenance.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion SIO_000772 12843186 NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_provenance.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion wasDerivedFrom befree-20140225 NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_provenance.
- NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_assertion wasGeneratedBy ECO_0000203 NP620215.RAwqCOeShdvWJMa4SrkwBos4p_9o-Nj6C6wjK96Z7ABhQ130_provenance.